Drug Reference
Dapagliflozin / Metformin
Combinations of oral blood glucose lowering drugs
Fact box
- Therapeutic class
- Combinations of oral blood glucose lowering drugs
Brand names
Xigduo
Available as
10 MG · Extended Release Oral Tablet5 MG · Extended Release Oral Tablet2.5 MG · Extended Release Oral Tablet
Multi-ingredient product
DapagliflozinMetformin
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [LUPIN PHARMACEUTICALS, INC.]
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NOVADOZ PHARMACEUTICALS LLC]
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [SUN PHARMACEUTICAL INDUSTRIES, INC.]
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED]
- DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [MACLEODS PHARMACEUTICALS LIMITED]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.